0000000000024924

AUTHOR

Markus Schmidt

showing 11 related works from this author

Dynamic MR imaging of breast lesions: correlation with microvessel distribution pattern and histologic characteristics of prognosis.

2006

To evaluate the association of dynamic enhancement parameters of benign and malignant breast lesions at magnetic resonance (MR) imaging with microvessel distribution and histologic prognostic tumor characteristics.Regional review board approval and informed consent were obtained. Surgical resection specimens of breast lesions (32 benign, 86 malignant) in 118 patients (age range, 28-86 years; mean, 58 years) who had undergone dynamic T1-weighted MR imaging of both breasts were included in the study. Different MR enhancement parameters and microvessel density (MVD) distribution were determined. In malignant lesions, TNM stage, tumor grade, proliferative activity, and hormone receptor expressi…

AdultMammary glandBreast NeoplasmsLesionsymbols.namesakemedicineCarcinomaHumansRadiology Nuclear Medicine and imagingStage (cooking)Lymph nodeMicrovesselFisher's exact testAgedAged 80 and overmedicine.diagnostic_testbusiness.industryMicrocirculationMagnetic resonance imagingMiddle Agedmedicine.diseasePrognosisMagnetic Resonance Imagingmedicine.anatomical_structuresymbolsmedicine.symptombusinessNuclear medicineRadiology
researchProduct

ErbB-3 predicts survival in ovarian cancer.

2006

Background HER3 (erbB-3) is a member of the epidermal growth factor receptor (EGFR) family. After dimerization with other members of the EGFR family several signal transduction cascades can be activated, including phosphoinosite 3′-kinase (PI3-K)/Akt and extracellular signal-regulated kinase (ERK1/2). Here, we studied a possible association between HER3 expression and prognosis in patients with ovarian cancer. Methods Tumor tissue of 116 consecutive patients diagnosed with primary epithelial ovarian cancer between 1986 and 1995 was analyzed immunohistochemically for HER3 expression. A possible influence of HER3 expression on survival was studied by multivariate Cox regression adjusting for …

OncologyCancer Researchmedicine.medical_specialtyReceptor ErbB-3Receptor ErbB-2ErbBPredictive Value of TestsInternal medicinemedicineBiomarkers TumorOdds RatioHumansEpidermal growth factor receptorStage (cooking)Protein kinase BNeoplasm StagingProportional Hazards ModelsGynecologyOvarian NeoplasmsbiologyProportional hazards modelbusiness.industryHazard ratioCarcinomaMiddle Agedmedicine.diseasePrognosisImmunohistochemistrySurvival AnalysisUp-RegulationGene Expression Regulation NeoplasticOncologyMultivariate Analysisbiology.proteinFemaleSignal transductionOvarian cancerbusinessJournal of clinical oncology : official journal of the American Society of Clinical Oncology
researchProduct

Surgical therapy of recurrent vulvar cancer.

2005

Objective The success of various surgical interventions in 201 cases with recurrent vulvar carcinoma was examined in the light of patients' pretreatment, surgical therapy, plastic reconstruction, and postoperative disease course. Study design A databank of standardized clinical data was analyzed using statistical procedures. Results Therapy was selected on an individual basis according to tumor status. Recurrence at a site distant from the primary tumor, particularly in the inguinal region, indicated a markedly unfavorable prognosis. In contrast, tumors recurring locally did not exhibit any significant differences. Plastic surgery reconstruction led to improvements with respect to operabili…

Adultmedicine.medical_specialtyReconstructive surgeryDatabases FactualVulvaTumor StatusGynecologic Surgical ProceduresmedicineHumansVulvar DiseasesAgedRecurrent Vulvar CarcinomaVulvar neoplasmAged 80 and overWound HealingVulvar Neoplasmsbusiness.industryCarcinomaObstetrics and GynecologyMiddle AgedPlastic Surgery Proceduresmedicine.diseasePrognosisPrimary tumorSurvival AnalysisSurgeryPlastic surgerymedicine.anatomical_structureFemaleNeoplasm Recurrence LocalbusinessAmerican journal of obstetrics and gynecology
researchProduct

(A)symptomatic necrotizing arteritis of the female genital tract.

2000

Abstract Aims: The vasculitides represent a heterogenous set of disorders that differ in prognosis and response to therapy. Beside systemic vasculitides, the development of localized forms of arteritis is well known though uncommon and the etiopathogenesis is not yet definitely clear. Methods: Patients with necrotizing arteritis of the female genital tract proven by histology are studied in a retrospective analysis. Results: Three cases of necrotizing arteritis with histological features of panarteritis nodosa apparently confined to the female genital tract are presented. None of these patients had prior history of systemic vasculitis. The acute necrotizing vasculitis was confined only to t…

Pathologymedicine.medical_specialtyCervix UteriNecrotizing VasculitismedicineHumansSex organArteritisMenorrhagiaFallopian TubesAgedRetrospective StudiesPolyarteritis nodosabusiness.industryVascular diseaseOvaryObstetrics and GynecologyGenitalia FemaleMiddle Agedmedicine.diseasePrognosisPolyarteritis NodosaReproductive MedicineMyometriumHistopathologyFemaleUterine HemorrhageVasculitisbusinessSystemic vasculitisEuropean journal of obstetrics, gynecology, and reproductive biology
researchProduct

The long journey towards standards for engineering biosystems: Are the Molecular Biology and the Biotech communities ready to standardise?

2020

Standards are the basis of technology: they allow rigorous description and exact measurement of properties, reliable reproducibility and a common “language” that enables different communities to work together. Molecular biology was in part created by physicists; yet, the field did not inherit the focus on the quantitation, the definition of system boundaries and the robust, unequivocal language that is characteristic of the other natural sciences. However, synthetic biology (SynBio) increasingly requires scientific, technical, operational and semantic standards for the field to become a full‐fledged engineering discipline with a high level of accuracy in the design, manufacturing and perfor…

0303 health sciencesEngineeringbusiness.industryManagement science0601 Biochemistry and Cell BiologyBiochemistry03 medical and health sciencesSynthetic biology0302 clinical medicineOrder (business)GeneticsComputingMethodologies_GENERALbusinessMolecular Biology030217 neurology & neurosurgeryDevelopmental Biology030304 developmental biology
researchProduct

Nuclear expression of apurinic/apyrimidinic endonuclease increases with progression of ovarian carcinomas.

2003

Apurinic/apyrimidinic endonuclease (APE alias Ref-1) is a key enzyme in the base excision repair pathway. Besides its function in DNA repair, APE serves to maintain several transcription factors in an active reduced state such as c-Fos, c-Jun, NF-kappaB, p53 and HIF-1alpha, all of which have been shown to play a role in tumorigenesis. Because of the importance of APE in maintaining genomic stability and gene regulation, we examined whether APE expression is associated with survival and histopathological parameters of patients with ovarian cancer.Tissue sections of primary epithelial ovarian carcinomas from 141 patients were immunostained using a monoclonal antibody directed against APE.Nucl…

DNA repairvirusesBiologymedicine.disease_causestomatognathic systemOvarian carcinomamedicineBiomarkers TumorDNA-(Apurinic or Apyrimidinic Site) LyaseHumansNeoplasm StagingRegulation of gene expressionCell NucleusOvarian NeoplasmsObstetrics and Gynecologysocial sciencesBase excision repairmedicine.diseasePrognosisMolecular biologyImmunohistochemistrybody regionsSurvival RateOncologyTumor progressionCancer researchDisease ProgressionImmunohistochemistryFemaleOvarian cancerCarcinogenesisGynecologic oncology
researchProduct

Undetected Malignancies of the Breast: Dynamic Contrast-enhanced MR Imaging at 1.0 T

2002

To assess the prevalence and characteristics of malignant breast lesions not identified with magnetic resonance (MR) imaging.Breast tissue specimens were obtained in 464 of 967 patients who had undergone dynamic gadolinium-enhanced T1-weighted fast low-angle shot three-dimensional MR imaging of both breasts. A comparison of sensitivity, specificity, and predictive values of the prospectively recorded findings of mammography, ultrasonography (US), and MR imaging with the histopathologic results was performed with receiver operating characteristic (ROC) curve analysis. MR imaging examination findings that caused a false-negative diagnosis were reviewed to identify possible sources of error.Hi…

medicine.medical_specialtyMammary glandBreast NeoplasmsGadoliniumSensitivity and SpecificityPredictive Value of TestsmedicineHumansMammographyRadiology Nuclear Medicine and imagingmedicine.diagnostic_testReceiver operating characteristicbusiness.industryCurve analysisMagnetic resonance imagingImage EnhancementMagnetic Resonance ImagingMr imagingDynamic contrastmedicine.anatomical_structureROC CurveFemaleHistopathologyUltrasonography MammaryRadiologyArtifactsNuclear medicinebusinessRadiology
researchProduct

Ovarian Endometrioid-like Yolk Sac Tumor Treated by Surgery Alone, with Recurrence at 12 Years

1999

Abstract We describe the case of a stage Ia endometrioid-like yolk sac tumor (YST) of the ovary, which was originally misdiagnosed as a malignant struma ovarii and not treated with adjuvant chemotherapy. After 12 years, a contralateral dermoid cyst was excised along with a small omental nodule of partially necrotic and calcified endometrioid-like YST. No tumor was detected in several other biopsy specimens, and a peritoneal lavage was negative for tumor cells. Since there was no evidence of remaining tumor and the serum α-fetoprotein (AFP) level was normal after the second operation, the patient was followed. Serial serum AFP levels remained normal for 4 months. At a second-look laparotomy …

AdultReoperationPathologymedicine.medical_specialtyTime Factorsmedicine.medical_treatmentOvaryLaparotomyBiopsyHumansMedicineYolk sacPeritoneal NeoplasmsOvarian Neoplasmsmedicine.diagnostic_testbusiness.industryEndodermal Sinus TumorObstetrics and GynecologyMalignant Struma Ovariimedicine.diseaseSurgerymedicine.anatomical_structureOncologyDermoid cystFemaleHistopathologyNeoplasm Recurrence LocalPouchbusinessOmentumGynecologic Oncology
researchProduct

Reconstructive plastic surgery in the treatment of vulvar carcinomas

2005

Abstract Objective The results obtained using plastic surgery reconstruction in 207 patients with a primary or recurrent vulvar carcinoma were analyzed with regard to the surgical procedures applied, pre-treatment and post-operative findings, along with the long-term oncological disease course. Study design Standardized data concerning the surgical procedures applied and clinical factors were collected in a databank and statistically analyzed. Results The flaps employed were termed either ‘local' (cutaneous or fasciocutaneous; n =84) or ‘regional' (myocutaneous, n =123). For local flaps, the rate of secondary healing was 31%, dropping to 20% for regional flaps. Such healing disturbances oft…

Adultmedicine.medical_specialtyThighSurgical FlapsDisease courseGynecologic Surgical ProceduresmedicineHumansSecondary healingAgedAged 80 and overRecurrent Vulvar CarcinomaWound HealingVulvar Neoplasmsbusiness.industryAdvanced stageObstetrics and GynecologyMiddle AgedPlastic Surgery Proceduresmedicine.diseaseSurvival AnalysisSurgeryPlastic surgeryStenosisTreatment Outcomemedicine.anatomical_structureReproductive MedicineFemaleVulvar CarcinomaNeoplasm Recurrence LocalbusinessEuropean Journal of Obstetrics & Gynecology and Reproductive Biology
researchProduct

Xenobiología: una nueva forma de vida o la última trinchera en bioseguridad

2012

Ciencias sociales. GeneralidadesUNESCO::CIENCIAS DE LAS ARTES Y LAS LETRAS:CIENCIAS DE LAS ARTES Y LAS LETRAS [UNESCO]Humanidades. GeneralidadesHumanidadesGrupo CCiencias socialesGrupo D
researchProduct

Prediction of paclitaxel resistance in breast cancer: is CYP1B1*3 a new factor of influence?

2008

This article focuses on the recent findings by Marsh and colleagues, and also discusses recent findings with regards to breast cancer. Taxanes are amongst the most active agents in the treatment of breast cancer. However, many tumors are intrinsically resistant. Therefore, it would be an enormous progress, if factors could be identified that reliably differentiate between taxane-sensitive and -resistant patients. Marsh and colleagues analyzed the CYP1B1*3 (Val432Leu) polymorphism in patients with high-risk stage III and IV breast cancer, who received dose-intense paclitaxel in combination with doxorubicin and cyclophosphamide. They report for the first time that patients with two leucine al…

Oncologymedicine.medical_specialtyCyclophosphamidePaclitaxelmedicine.medical_treatmentBreast NeoplasmsDisease-Free Survivalchemistry.chemical_compoundBreast cancerCytochrome P-450 Enzyme SystemInternal medicineGenotypeGeneticsAdjuvant therapyMedicineHumansDoxorubicinProgression-free survivalPharmacologyChemotherapyPolymorphism GeneticDose-Response Relationship Drugbusiness.industrymedicine.diseaseAntineoplastic Agents Phytogenicbody regionsPaclitaxelchemistryDrug Resistance NeoplasmImmunologyCytochrome P-450 CYP1B1Molecular MedicineFemaleAryl Hydrocarbon Hydroxylasesbusinessmedicine.drugPharmacogenomics
researchProduct